AI assistant
Sending…
KIORA PHARMACEUTICALS INC — Director's Dealing 2021
Apr 14, 2021
35256_dirs_2021-04-14_e569706d-f3ec-4d27-9864-5f4337d6d949.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 3 — Initial Statement of Beneficial Ownership
Issuer: EYEGATE PHARMACEUTICALS INC (EYEG)
CIK: 0001372514
Period of Report: 2021-04-01
Reporting Person: Gayron Kenneth L (Director)
More from KIORA PHARMACEUTICALS INC
Share Issue/Capital Change
2026
May 28
Regulatory Filings
2026
May 18
Earnings Release
2026
May 8
Interim / Quarterly Report
2026
May 8
Annual Report
2026
May 1
Capital/Financing Update
2026
Apr 7
Board/Management Information
2026
Apr 2
Capital/Financing Update
2026
Mar 25
Earnings Release
2026
Mar 25
Annual Report
2026
Mar 25